查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1936772

2026-2034年全球心臟再同步治疗设备市场规模、份额、趋势和成长分析报告

Global Cardiac Resynchronization Therapy Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 112 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计心臟再同步治疗（CRT）设备市场规模将从 2025 年的 55.3 亿美元成长到 2034 年的 89.3 亿美元，2026 年至 2034 年的复合年增长率为 5.47%。

由于心臟衰竭盛行率不断上升以及人们对先进治疗方案的认知度日益提高，全球心臟再同步治疗（CRT）设备市场预计将迎来显着增长。 CRT设备，包括心律调节器和植入式心臟整流去颤器（ICD），旨在改善心臟衰竭患者的心臟和心臟功能。随着医疗机构寻求有效治疗心臟疾病的解决方案，CRT设备的应用预计将显着增加，从而推动这一重要市场的创新和投资。

此外，CRT技术的进步和设备设计的创新预计将进一步推动市场成长。新一代CRT设备的研发，例如具备远端监测功能和更长电池续航力等增强特性，有助于改善患者的治疗效果和便利性。此外，对个人化医疗和以病人为中心的照护的日益重视，也推动了对可根据患者个别需求量身定制的CRT设备的需求。随着医疗保健格局的不断演变，心臟再同步治疗设备市场预计将迎来对能够改善患者照护和生活品质的创新解决方案的激增。

此外，对监管合规性和临床证据的日益重视也将塑造CRT设备市场的未来。随着监管机构实施更严格的设备核准和监管指南，对符合这些标准的CRT设备的需求将持续成长。设备製造商、医疗服务提供者和监管机构之间的合作对于推动这些进步至关重要，并确保心臟再同步治疗设备市场始终处于心血管创新领域的前沿。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球心臟再同步治疗设备市场（依产品划分）

  • 市场分析、洞察与预测
  • CRT去心房颤动
  • CRT心律调节器

5. 全球心臟再同步治疗设备市场（依最终用途划分）

  • 市场分析、洞察与预测
  • 医院
  • 心臟中心
  • 其他的

6. 全球心臟再同步治疗设备市场（依地区划分）

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商格局（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medtronic
    • Abbott
    • Boston Scientific Corporation
    • Biotronik SE & Co. KG
    • MicroPort Scientific Corporation
    • LivaNova Plc
    • Asahi Kasei Medical Co.Ltd
    • Nihon Kohden Corporation
    • Schiller AG
    • Medico SPA
简介目录
Product Code: VMR11212560

The Cardiac Resynchronization Therapy Devices Market size is expected to reach USD 8.93 Billion in 2034 from USD 5.53 Billion (2025) growing at a CAGR of 5.47% during 2026-2034.

The global cardiac resynchronization therapy (CRT) devices market is poised for significant growth, driven by the increasing prevalence of heart failure and the growing awareness of advanced treatment options. CRT devices, which include pacemakers and implantable cardioverter-defibrillators, are designed to improve the heart's rhythm and function in patients with heart failure. As healthcare providers seek effective solutions to manage heart conditions, the adoption of CRT devices is expected to rise substantially, fostering innovation and investment in this critical market.

Moreover, advancements in CRT technology and device design are anticipated to further boost market growth. The development of next-generation CRT devices with enhanced features, such as remote monitoring capabilities and improved battery life, is enhancing patient outcomes and convenience. Additionally, the growing emphasis on personalized medicine and patient-centered care is driving the demand for CRT devices that can be tailored to individual patient needs. As the healthcare landscape continues to evolve, the market for cardiac resynchronization therapy devices is likely to witness a surge in demand for innovative solutions that improve patient care and quality of life.

In addition, the increasing focus on regulatory compliance and clinical evidence is expected to shape the future of the CRT devices market. As regulatory bodies implement stricter guidelines for device approval and monitoring, the demand for CRT devices that meet these standards will continue to rise. Collaborative efforts between device manufacturers, healthcare providers, and regulatory agencies will be essential in driving these advancements, ensuring that the cardiac resynchronization therapy devices market remains at the forefront of cardiovascular innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • CRT-Defibrillator
  • CRT-Pacemaker

By End-use

  • Hospital
  • Cardiac Center
  • Others

COMPANIES PROFILED

  • Medtronic, Abbott, Boston Scientific Corporation, Biotronik SE Co KG, MicroPort Scientific Corporation, LivaNova plc, Asahi Kasei Medical Co, Ltd, Nihon Kohden Corporation, Schiller AG, Medico SpA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. CRT-Defibrillator Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. CRT-Pacemaker Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-use
  • 5.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cardiac Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End-use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End-use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End-use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End-use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End-use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Medtronic
    • 8.2.2 Abbott
    • 8.2.3 Boston Scientific Corporation
    • 8.2.4 Biotronik SE & Co. KG
    • 8.2.5 MicroPort Scientific Corporation
    • 8.2.6 LivaNova Plc
    • 8.2.7 Asahi Kasei Medical Co.Ltd
    • 8.2.8 Nihon Kohden Corporation
    • 8.2.9 Schiller AG
    • 8.2.10 Medico S.P.A